• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia.

作者信息

Musallam Khaled M, Barella Susanna, Origa Raffaella, Ferrero Giovanni Battista, Lisi Roberto, Pasanisi Annamaria, Longo Filomena, Gianesin Barbara, Forni Gian Luca

机构信息

Center for Research on Rare Blood Disorders, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy.

出版信息

Blood. 2024 Mar 7;143(10):930-932. doi: 10.1182/blood.2023022460.

DOI:10.1182/blood.2023022460
PMID:37976447
Abstract
摘要

相似文献

1
Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia.输血依赖型β地中海贫血成人患者输血前血红蛋白水平与死亡率
Blood. 2024 Mar 7;143(10):930-932. doi: 10.1182/blood.2023022460.
2
Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major.重型地中海贫血患者输血前血红蛋白水平的季节性变化
Blood. 2006 Jan 1;107(1):355-7. doi: 10.1182/blood-2005-03-1231. Epub 2005 Sep 22.
3
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.适度输血方案可能会减少重型β地中海贫血患者的铁负荷，而不会导致红细胞生成过度增加。
Transfusion. 1997 Feb;37(2):135-40. doi: 10.1046/j.1537-2995.1997.37297203514.x.
4
Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka.β-地中海贫血和血红蛋白 Eβ-地中海贫血的输血治疗：斯里兰卡的充分性、趋势和决定因素。
Pediatr Blood Cancer. 2019 May;66(5):e27643. doi: 10.1002/pbc.27643. Epub 2019 Jan 29.
5
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia.非输血依赖型β地中海贫血患者血红蛋白水平的变化及发病负担
Ann Hematol. 2021 Jul;100(7):1903-1905. doi: 10.1007/s00277-021-04456-5. Epub 2021 Feb 11.
6
Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study.非输血依赖型β地中海贫血的无病生存率和血红蛋白水平：一项10年队列研究
Ann Hematol. 2022 Jan;101(1):203-204. doi: 10.1007/s00277-020-04370-2. Epub 2021 Jan 20.
7
Deformability of transfused red blood cells is a potent effector of transfusion-induced hemoglobin increment: A study with β-thalassemia major patients.输注红细胞的可变形性是输血诱导血红蛋白增加的有力影响因素：一项针对重型β地中海贫血患者的研究。
Am J Hematol. 2017 Sep;92(9):E559-E560. doi: 10.1002/ajh.24821. Epub 2017 Jul 19.
8
Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.输血抑制成年重型β地中海贫血患者的红细胞生成并增加其铁调素：一项纵向研究。
Blood. 2013 Jul 4;122(1):124-33. doi: 10.1182/blood-2012-12-471441. Epub 2013 May 8.
9
Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia.羟基脲可以消除重度β地中海贫血患儿的输血需求。
Blood. 2003 Aug 15;102(4):1529-30. doi: 10.1182/blood-2003-01-0117. Epub 2003 Apr 17.
10
High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.β地中海贫血/Hb E患儿的大量输血：18例临床及实验室评估
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:96-9.

引用本文的文献

1
Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.罗特西普用于输血依赖型β地中海贫血：来自意大利大量患者队列的真实世界经验
Am J Hematol. 2025 Sep;100(9):1651-1655. doi: 10.1002/ajh.27758. Epub 2025 Jul 1.
2
Luspatercept in Transfusion-Dependent β-Thalassemia: The Benefit Is Real, and So Are the Risks.罗特西普用于输血依赖型β地中海贫血：益处是实实在在的，风险亦是如此。
Am J Hematol. 2025 Sep;100(9):1480-1482. doi: 10.1002/ajh.27745. Epub 2025 Jun 19.
3
[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)].
[2025年中国儿童输血依赖型地中海贫血输血管理指南]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 May 15;27(5):505-514. doi: 10.7499/j.issn.1008-8830.2410119.
4
Transfusion probability as an alternative measure of lab-guided medical decision-making.输血概率作为实验室指导医疗决策的一种替代指标。
Transfusion. 2025 May;65(5):921-936. doi: 10.1111/trf.18235. Epub 2025 Apr 2.
5
A one-base therapeutic insertion in the HBG2 distal promoter reactivates γ-globin expression.在HBG2远端启动子中进行单碱基治疗性插入可重新激活γ-珠蛋白表达。
Exp Hematol Oncol. 2025 Mar 28;14(1):47. doi: 10.1186/s40164-025-00626-7.
6
Real Life Blood Management Practices in Thalassemia and Myelodysplastic Syndrome Patients.地中海贫血和骨髓增生异常综合征患者的真实血液管理实践
Anemia. 2025 Jan 8;2025:7257391. doi: 10.1155/anem/7257391. eCollection 2025.
7
Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study.β地中海贫血患者的人口统计学、临床特征及真实世界治疗模式：一项回顾性病历摘要研究
Ther Adv Hematol. 2024 Dec 15;15:20406207241298088. doi: 10.1177/20406207241298088. eCollection 2024.
8
Luspatercept: a treatment for ineffective erythropoiesis in thalassemia.罗特西普：一种治疗地中海贫血无效红细胞生成的药物。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):419-425. doi: 10.1182/hematology.2024000567.